The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether memory problems ...

Roche Diagnostics said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's blood test as an ...

Please provide your email address to receive an email when new articles are posted on . Testing revealed significant cognitive differences between patients with Alzheimer’s or dementia and healthy ...

Alzheimer's disease is a heartbreaking and complicated condition, slowly taking away memory, thinking, and independence.

Researchers say the experimental tool has huge implications for public health, especially in conjunction with Alzheimer’s drugs that are most effective in the disease’s early stages ...

The FDA recently cleared the Lumipulse blood test for early diagnosis of Alzheimer's disease in people 55 and over with memory loss. The noninvasive Lumipulse blood test measures the levels of two ...

A less invasive test for Alzheimer’s is a big advance. But it’s not perfect and is not meant to screen healthy people.

Breakthrough research from the University of Bath and the University of Bristol that demonstrates the real-world efficacy of a passive EEG test in identifying memory decline years before a clinical ...

The U.S. FDA has approved Roche and Eli Lilly’s new Elecsys pTau181 blood test to help detect Alzheimer’s disease in people ...

In many cases, it's not until memory problems start creeping up that most people learn they have Alzheimer's disease. By then, the disease may already be progressing, leaving limited options for ...

Scientists have designed a new cognitive test that diagnoses patients more accurately with Alzheimer's. The digital test times how long it takes patients to remember objects and make word associations ...

A Corewell Health memory care clinic is working to bridge the gap in dementia detection and treatment for West Michigan’s ...